IRAK inhibitor can improve insulin sensitivity in insulin-resistant mice fed with a high-fat diet

[1]Rines AK, Sharabi K, Tavares CDJ, Puigserver P. Targeting hepatic glucose metabolism in the treatment of type 2 diabetes. Nat Rev Drug Discov. 2016; 15:786–804.RinesAKSharabiKTavaresCDJPuigserverPTargeting hepatic glucose metabolism in the treatment of type 2 diabetesNat Rev Drug Discov20161578680410.1038/nrd.2016.151575142127516169Search in Google Scholar

[2]Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008; 9:367–77.GuilhermeAVirbasiusJVPuriVCzechMPAdipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetesNat Rev Mol Cell Biol200893677710.1038/nrm2391288698218401346Search in Google Scholar

[3]Akter S, Rahman MM, Abe SK, Sultana P. Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey. Bull World Health Organ. 2014; 92:204–13A.AkterSRahmanMMAbeSKSultanaPPrevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide surveyBull World Health Organ20149220413A10.2471/BLT.13.128371394959624700980Search in Google Scholar

[4]Gross B, Pawlak M, Lefebvre P, Staels B. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol. 2017; 13:36–49.GrossBPawlakMLefebvrePStaelsBPPARs in obesity-induced T2DM, dyslipidaemia and NAFLDNat Rev Endocrinol201713364910.1038/nrendo.2016.13527636730Search in Google Scholar

[5]Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006; 444(7121):840–6.KahnSEHullRLUtzschneiderKMMechanisms linking obesity to insulin resistance and type 2 diabetesNature20064447121840610.1038/nature0548217167471Search in Google Scholar

[6]Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005; 26:19–39.WilcoxGInsulin and insulin resistanceClin Biochem Rev2005261939Search in Google Scholar

[7]Shah A, Mehta N, Reilly MP. Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J Parenter Enteral Nutr. 2008; 32:638–44.ShahAMehtaNReillyMPAdipose inflammation, insulin resistance, and cardiovascular diseaseJPEN J Parenter Enteral Nutr2008326384410.1177/0148607108325251308811018974244Search in Google Scholar

[8]Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016; 126:12–22.SamuelVTShulmanGIThe pathogenesis of insulin resistance: integrating signaling pathways and substrate fluxJ Clin Invest2016126122210.1172/JCI77812470154226727229Search in Google Scholar

[9]Esteve E, Ricart W, Fernández-Real JM. Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care. 2009; 32(Suppl 2):S362–7.EsteveERicartWFernández-RealJMAdipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectinDiabetes Care200932Suppl 2S362710.2337/dc09-S340281145319875582Search in Google Scholar

[10]Hirabara SM, Gorjão R, Vinolo MA, Rodrigues AC, Nachbar RT, Curi R. Molecular targets related to inflammation and insulin resistance and potential interventions. J Biomed Biotechnol. 2012; 2012:379024. doi: 10.1155/2012/379024HirabaraSMGorjãoRVinoloMARodriguesACNachbarRTCuriRMolecular targets related to inflammation and insulin resistance and potential interventionsJ Biomed Biotechnol2012201237902410.1155/2012/379024346319823049242Open DOISearch in Google Scholar

[11]de Luca C, Olefsky JM. Inflammation and Insulin Resistance. FEBS Lett. 2008; 582:97–105.de LucaCOlefskyJMInflammation and Insulin ResistanceFEBS Lett20085829710510.1016/j.febslet.2007.11.057224608618053812Search in Google Scholar

[12]Chen L, Chen R, Wang H, Liang F. Mechanisms linking inflammation to insulin resistance. Int J Endocrinol. 2015; 2015:508409. doi: 10.1155/2015/508409ChenLChenRWangHLiangFMechanisms linking inflammation to insulin resistanceInt J Endocrinol2015201550840910.1155/2015/508409446829226136779Open DOISearch in Google Scholar

[13]Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem. 2009; 42:1331–46.MeshkaniRAdeliKHepatic insulin resistance, metabolic syndrome and cardiovascular diseaseClin Biochem20094213314610.1016/j.clinbiochem.2009.05.01819501581Search in Google Scholar

[14]Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006; 13:816–25.KawaiTAkiraSTLR signalingCell Death Differ2006138162510.1038/sj.cdd.440185016410796Search in Google Scholar

[15]Rhyasen GW, Starczynowski DT. IRAK signalling in cancer. Br J Cancer. 2015; 112:232–7.RhyasenGWStarczynowskiDTIRAK signalling in cancerBr J Cancer2015112232710.1038/bjc.2014.513445344125290089Search in Google Scholar

[16]Winzell MS, Ahrén B. The high-fat diet–fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes. 2004; 53(Suppl 3):S215–9.WinzellMSAhrénBThe high-fat diet–fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetesDiabetes200453Suppl 3S215910.2337/diabetes.53.suppl_3.S21515561913Search in Google Scholar

[17]Wang C-Y, Liao JK. A mouse model of diet-induced obesity and insulin resistance. In: Weichhart T, editor. mTOR. Methods in molecular biology (methods and protocols), vol. 821. Totowa, NJ: Humana Press; 2012, p. 421–33.WangC-YLiaoJKA mouse model of diet-induced obesity and insulin resistanceIn:WeichhartTeditor.mTOR. Methods in molecular biology (methods and protocols)821Totowa, NJHumana Press20124213310.1007/978-1-61779-430-8_27380709422125082Search in Google Scholar

[18]Srinivasan K, Patole PS, Kaul CL, Ramarao P. Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol. 2004; 26:327–33.SrinivasanKPatolePSKaulCLRamaraoPReversal of glucose intolerance by by pioglitazone in high fat diet-fed ratsMethods Find Exp Clin Pharmacol2004263273310.1358/mf.2004.26.5.83132215319810Search in Google Scholar

[19]Yadav H, Jain S, Yadav M, Sinha PR, Prasad GBKS, Marotta F. Epigenomic derangement of hepatic glucose metabolism by feeding of high fructose diet and its prevention by Rosiglitazone in rats. Dig Liver Dis. 2009; 41:500–8.YadavHJainSYadavMSinhaPRPrasadGBKSMarottaFEpigenomic derangement of hepatic glucose metabolism by feeding of high fructose diet and its prevention by Rosiglitazone in ratsDig Liver Dis200941500810.1016/j.dld.2008.11.01219196556Search in Google Scholar

[20]Li Z, Younger K, Gartenhaus R, Joseph AM, Hu F, Baer MR, et al. Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies. J Clin Invest. 2015; 125:1081–97.LiZYoungerKGartenhausRJosephAMHuFBaerMRInhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapiesJ Clin Invest201512510819710.1172/JCI75821436224325642772Search in Google Scholar

[21]Mohammadi GA, Danesh B, Fallah H, Rahemi S. The effect of co-administration of Pioglitazone and simvastatin on insulin resistance parameters and PPAR.γ expression in insulin-resistant rats. J Kerman Univ Med Sci. 2017; 24:16–27.MohammadiGADaneshBFallahHRahemiSThe effect of co-administration of Pioglitazone and simvastatin on insulin resistance parameters and PPAR.γ expression in insulin-resistant ratsJ Kerman Univ Med Sci2017241627Search in Google Scholar

[22]Mohammadi A, Fallah H, Gholamhosseinian A. Antihyperglycemic effect of Rosa damascena is mediated by PPAR.γ gene expression in animal model of insulin resistance. Iran J Pharm Res. 2017; 16:1080–8.MohammadiAFallahHGholamhosseinianAAntihyperglycemic effect of Rosa damascena is mediated by PPAR.γ gene expression in animal model of insulin resistanceIran J Pharm Res20171610808Search in Google Scholar

[23]Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. 2015; 19:160–4.GutchMKumarSRaziSMGuptaKKGuptaAAssessment of insulin sensitivity/resistanceIndian J Endocrinol Metab201519160410.4103/2230-8210.146874428776325593845Search in Google Scholar

[24]Cariou B, Charbonnel B, Staels B. Thiazolidinediones and PPARγ agonists: time for a reassessment. Trends Endocrinol Metab. 2012; 23:205–15.CariouBCharbonnelBStaelsBThiazolidinediones and PPARγ agonists: time for a reassessmentTrends Endocrinol Metab2012232051510.1016/j.tem.2012.03.00122513163Search in Google Scholar

[25]Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia. 2008; 51:8–11.NathanDMBuseJBDavidsonMBFerranniniEHolmanRRSherwinRZinmanBManagement of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapyUpdate regarding the thiazolidinediones. Diabetologia20085181110.1007/s00125-007-0873-z18026926Search in Google Scholar

[26]Sun X-J, Kim SP, Zhang D, Sun H, Cao Q, Lu X, et al. Deletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing sensitivity in skeletal muscle. J Biol Chem. 2017; 292:12339–50.SunX-JKimSPZhangDSunHCaoQLuXDeletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing sensitivity in skeletal muscleJ Biol Chem2017292123395010.1074/jbc.M117.779108551938028572512Search in Google Scholar

[27]Rajaie A, Allahyari M, Nazari-Robati M, Fallah H. Inhibition of interleukin-1 receptor-associated kinases 1/4, increases gene expression and serum level of adiponectin in mouse model of insulin resistance. Int J Mol Cell Med. 2018; 7: 185–92.RajaieAAllahyariMNazari-RobatiMFallahHInhibition of interleukin-1 receptor-associated kinases 1/4, increases gene expression and serum level of adiponectin in mouse model of insulin resistanceInt J Mol Cell Med.2018718592Search in Google Scholar

[28]Geagea AG, Mallat S, Matar CF, Zerbe R, Filfili E, Francis M, et al. Adiponectin and inflammation in health and disease: an update. Open Med J. 2018; 5:20–32.GeageaAGMallatSMatarCFZerbeRFilfiliEFrancisMAdiponectin and inflammation in health and disease: an updateOpen Med J20185203210.2174/1874220301805010020Search in Google Scholar

[29]Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017; 2:e17023. doi: 10.1038/sigtrans.2017.23LiuTZhangLJooDSunS-CNF-κB signaling in inflammationSignal Transduct Target Ther20172e1702310.1038/sigtrans.2017.23566163329158945Open DOISearch in Google Scholar

[30]Francken AB, Schouten PC, Bleiker EMA, Linn SC, Rutgers EJTh. Breast cancer in women at high risk: the role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies. Breast. 2013; 22:561–8.FranckenABSchoutenPCBleikerEMALinnSCRutgersEJThBreast cancer in women at high risk: the role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategiesBreast201322561810.1016/j.breast.2013.07.04523972475Search in Google Scholar

[31]Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab. 2002; 87:2784–91MiyazakiYMahankaliAMatsudaMMahankaliSHardiesJCusiKEffect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patientsJ Clin Endocrinol Metab20028727849110.1210/jcem.87.6.856712050251Search in Google Scholar

[32]Ahmad R, Shihab PK, Thomas R, Alghanim M, Hasan A, Sindhu S, Behbehani K. Increased expression of the interleukin-1 receptor-associated kinase (IRAK)-1 is associated with adipose tissue inflammatory state in obesity. Diabetol Metab Syndr. 2015; 7:71. doi: 10.1186/s13098-015-0067-7AhmadRShihabPKThomasRAlghanimMHasanASindhuSBehbehaniKIncreased expression of the interleukin-1 receptor-associated kinase (IRAK)-1 is associated with adipose tissue inflammatory state in obesityDiabetol Metab Syndr201577110.1186/s13098-015-0067-7454983226312071Open DOISearch in Google Scholar